Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 3/20 | 0.36 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.36 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.36 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | HTR2C | P28335 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | HRH1 | P35367 | 1/20 | 0.36 |
| ▸ | DRD3 | P35462 | 1/20 | 0.36 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.34 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.32 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.32 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7159187 | 0.87 | TP53 (0.39) | TSHRTP53FDPS | |
| SCHEMBL27533149 | 0.84 | TP53 (0.46) | TP53FDPS | |
| SCHEMBL27360518 | 0.81 | — | — | |
| SCHEMBL28154220 | 0.79 | CA12 (0.30) | — | |
| SCHEMBL27497599 | 0.77 | — | — | |
| SCHEMBL6721961 | 0.77 | HDAC1 (0.36) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL8719513 | 0.76 | — | — | |
| SCHEMBL11831825 | 0.71 | SLC22A6 (0.36) | — | |
| SCHEMBL18222446 | 0.71 | CHRM1 (0.31) | HDAC1HDAC2CHRM1AKR1A1CHRM3 | |
| SCHEMBL19419153 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1288499-C | Radiation-sensitive resin composition | JSR CORP (JP) | 2006-12-06 | — | — | CN | disclosed |
| CN-1501166-A | Radiation-sensitive resin composition | JSR株式会社 | 2004-06-02 | — | — | CN | disclosed |
| US-20030095924-A1 | Galenical formulations | SCHERING AKTIENGESELLSCHAFT (DE) | 2003-05-22 | — | — | US | disclosed |
| US-6447749-B1 | Perfluoro-alkyl containing dye molecules and galencial formulations | SCHERING AKTIENGESELLSCHAFT (DE) | 2002-09-10 | — | — | US | disclosed |
| CN-1336914-A | Method for producing 2-hydroxy-4-methylthiobutanoic acid | SUMITOMO CHEMICAL CO (JP) | 2002-02-20 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030095924-A1 | Galenical formulations | GALR1, GALR2, LGALS1 | HDAC1 4245/4885HDAC2 3536/4885CHRM1 420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.